GC
WuXi AppTec nets $950m from H-share tap
Chinese pharmaceutical company WuXi AppTec has raised HK$7.37bn ($950.4m) of fresh equity, in a hotly-anticipated tap of a new mandate to issue A-shares and H-shares.
WuXi first announced plans to issue new stock in Hong Kong and on the Mainland in March this year, aiming to raise up to Rmb6.5bn ($928.1m) from an A-share placement and an unspecified amount from a sale of H-shares.
The firm was eyeing capital to help fund ...Already a subscriber? Login
